Frontlight ResearchEarly access
Active, not recruitingNo phase
Myopia Control Efficacy of Second-generation DIMS Spectacle Lenses on Fast Progressing Myopes
Key facts
- Who runs it
- The Hong Kong Polytechnic University
- Where
- Hong Kong1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 118 people, planned
- Started
- 29 Jul 2023
- Expected to end
- 31 Dec 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Variant of Defocus Incorporated Spectacle lens (DG2)
- Record updated
- 22 April 2026
Who can take part
- Age
- 4 years to 12 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- SER: -0.75D or below in both eyes
- Documented history of fast progressing myopia, either in SER or AL; SER progression: 0.50D/year or more; AL elongation: 0.27mm/year or more; For children aged 4-6 years without past prescription forms,; 4-5 years old: myopia of -0.75D or below in both eyes; 6 years old: myopia of -1.25D or below in at least one eye, with the other eye -0.75D or below
- Best-corrected visual acuity (VA) in both eyes:; 4 - 6 years old: 0.20 logMAR (or its equivalent) or better; 7-12 years old: 0.00 logMAR (or its equivalent) or better
- Acceptance of random group allocation and the masked study design
- Anisometropia of 1.50 D or less
- Astigmatism of 2.00 D or less
Who cannot take part
- Prior experience of myopia control
- Strabismus and binocular vision abnormalities
- Ocular and systemic abnormalities
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to examine the efficacy and performance of the variant of Defocus Incorporated Spectacle lenses on controlling myopia progression in fast progressing myopic children.
The 2 groups in the trial
- Single vision lens groupNo study treatment, for comparison
Subjects in single vision lens group will receive a pair of single vision lenses for the first year of study. They will then receive a pair of DG2 lenses for an additional 3 years.
- D2 lens groupTreatment being tested
Subjects in D2 lens group will receive a pair of D2 lenses over the 4-year study.
Treatment: Variant of Defocus Incorporated Spectacle lens (DG2)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Myopia Control Effectiveness of Second-generation Defocus Incorporated Multiple Segments Spectacle Lenses on Fast Progressing Myopes: A Randomized Controlled Trial
- Publications
- Record updated
- 22 April 2026